相关实验视频
Updated: Sep 13, 2025

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
雷尼福明A通过诱导DRP1-介导的线粒体功能障碍和亡来抑制三阴性乳腺癌的进展
Yifei Guan1, Lei Liu2, Wei Wang3
1Beijing Key Laboratory of Environmental and Viral Oncology, Beijing International Science and Technology Cooperation Base for Antiviral Drugs, College of Chemistry and Life Science, Beijing University of Technology, Beijing, China.
雷尼福林A对三阴性乳腺癌 (TNBC) 具有显著的抗癌作用. 它通过与DRP1和BAX蛋白相互作用触发线粒体功能障碍和亡来起作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有有限治疗选择的侵袭性亚型.
- 来自Isodon excisoides的天然化合物雷尼福明A (RA) 已显示出瘤抑制作用,但其在TNBC中的作用尚不清楚.
研究的目的:
- 研究雷尼福尔A (RA) 在三阴性乳腺癌 (TNBC) 中的抗癌作用和分子机制.
主要方法:
- 分子对接模拟以确定RA的绑定目标.
- 在体外测试以验证相互作用并评估细胞效应.
- 在体内研究以评估治疗疗效.
主要成果:
- 雷尼福明A (RA) 通过诱导线粒体功能障碍和内在亡,对TNBC表现出显著的抗癌活性.
- 在两个结合位点上,RA与DRP1直接相互作用,促进DRP1-BAX关联和线粒体转移.
- 干扰RA-DRP1相互作用抑制了亡,并降低了RA的 in vitro 和 in vivo 疗效.
结论:
- 雷尼福明A (RA) 通过诱导DRP1/BAX介导的线粒体亡来抑制TNBC的进展.
- 准RA-DRP1相互作用为TNBC治疗提供了一个潜在的治疗策略.
更多相关视频
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
12:28Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
相关概念视频
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules
PI3K/mTOR/AKT Signaling Pathway
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway